Home > Research > Publications & Outputs > Bandit Procedures for Designing Patient-Centric...

Links

Text available via DOI:

View graph of relations

Bandit Procedures for Designing Patient-Centric Clinical Trials

Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter

Published

Standard

Bandit Procedures for Designing Patient-Centric Clinical Trials. / Villar, Sofia S.; Jacko, Peter.
Springer Series in Supply Chain Management. ed. / Xi Chen; Stefanus Jasin; Cong Shi. 1. ed. London: Springer Nature, 2022. p. 365-389 (Springer Series in Supply Chain Management; Vol. 18).

Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter

Harvard

Villar, SS & Jacko, P 2022, Bandit Procedures for Designing Patient-Centric Clinical Trials. in X Chen, S Jasin & C Shi (eds), Springer Series in Supply Chain Management. 1 edn, Springer Series in Supply Chain Management, vol. 18, Springer Nature, London, pp. 365-389. https://doi.org/10.1007/978-3-031-01926-5_14

APA

Villar, S. S., & Jacko, P. (2022). Bandit Procedures for Designing Patient-Centric Clinical Trials. In X. Chen, S. Jasin, & C. Shi (Eds.), Springer Series in Supply Chain Management (1 ed., pp. 365-389). (Springer Series in Supply Chain Management; Vol. 18). Springer Nature. https://doi.org/10.1007/978-3-031-01926-5_14

Vancouver

Villar SS, Jacko P. Bandit Procedures for Designing Patient-Centric Clinical Trials. In Chen X, Jasin S, Shi C, editors, Springer Series in Supply Chain Management. 1 ed. London: Springer Nature. 2022. p. 365-389. (Springer Series in Supply Chain Management). doi: 10.1007/978-3-031-01926-5_14

Author

Villar, Sofia S. ; Jacko, Peter. / Bandit Procedures for Designing Patient-Centric Clinical Trials. Springer Series in Supply Chain Management. editor / Xi Chen ; Stefanus Jasin ; Cong Shi. 1. ed. London : Springer Nature, 2022. pp. 365-389 (Springer Series in Supply Chain Management).

Bibtex

@inbook{798da1383f304b40b61f06c3fcb28edc,
title = "Bandit Procedures for Designing Patient-Centric Clinical Trials",
abstract = "Multi-armed bandit problems (MABPs) are a special type of optimal control problem that has been studied in the fields of operations research, statistics, machine learning, economics, and others. It is a framework well suited to model resource allocation under uncertainty in a wide variety of contexts. Across the existing theoretical literature, the use of bandit models to optimally design clinical trials is one of the most typical motivating application, where the word “optimally” refers to designing the so-called patient-centric trials, which would take into account the benefit of the in-trial patients and thus are by some researchers considered more ethical. Nevertheless, the resulting theory has had little influence on the actual design of clinical trials. Contrary to similar learning problems arising for instance in digital marketing where interventions can be tested on millions of users at negligible cost, clinical trials are about “small data”, as recruiting patients is remarkably expensive and (in many cases) ethically challenging. In this book chapter, we review a variety of operations research and machine learning approaches that lead to algorithms to “solve” the finite-horizon MABP and then interpret them in the context of designing clinical trials. Due to the focus on small sizes, we do not resort to the use of the normal distribution to approximate a binomial distribution which is a common practice for large samples either “for simplicity” or “for ease of computation”. Solving a MABP essentially means to derive a response-adaptive procedure for allocating patients to arms in a finite sample experiment with no early stopping. We evaluate and compare the performance of these procedures, including the traditional and still dominant clinical trial design choice: equal fixed randomization. Our results illustrate how bandit approaches could offer significant advantages, mainly in terms of allocating more patients to better interventions, but still pose important inferential challenges, particularly in terms of their resulting lower statistical power, potential for bias in estimation and existence of closed-form test distributions or asymptotic theory. We illustrate some promising modifications to bandit procedures to address power and bias issues, and we reflect upon the open challenges that remain for an increased uptake of bandit models in clinical trials.",
author = "Villar, {Sofia S.} and Peter Jacko",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.",
year = "2022",
month = sep,
day = "21",
doi = "10.1007/978-3-031-01926-5_14",
language = "English",
isbn = "9783031019258",
series = "Springer Series in Supply Chain Management",
publisher = "Springer Nature",
pages = "365--389",
editor = "Xi Chen and Stefanus Jasin and Cong Shi",
booktitle = "Springer Series in Supply Chain Management",
edition = "1",

}

RIS

TY - CHAP

T1 - Bandit Procedures for Designing Patient-Centric Clinical Trials

AU - Villar, Sofia S.

AU - Jacko, Peter

N1 - Publisher Copyright: © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.

PY - 2022/9/21

Y1 - 2022/9/21

N2 - Multi-armed bandit problems (MABPs) are a special type of optimal control problem that has been studied in the fields of operations research, statistics, machine learning, economics, and others. It is a framework well suited to model resource allocation under uncertainty in a wide variety of contexts. Across the existing theoretical literature, the use of bandit models to optimally design clinical trials is one of the most typical motivating application, where the word “optimally” refers to designing the so-called patient-centric trials, which would take into account the benefit of the in-trial patients and thus are by some researchers considered more ethical. Nevertheless, the resulting theory has had little influence on the actual design of clinical trials. Contrary to similar learning problems arising for instance in digital marketing where interventions can be tested on millions of users at negligible cost, clinical trials are about “small data”, as recruiting patients is remarkably expensive and (in many cases) ethically challenging. In this book chapter, we review a variety of operations research and machine learning approaches that lead to algorithms to “solve” the finite-horizon MABP and then interpret them in the context of designing clinical trials. Due to the focus on small sizes, we do not resort to the use of the normal distribution to approximate a binomial distribution which is a common practice for large samples either “for simplicity” or “for ease of computation”. Solving a MABP essentially means to derive a response-adaptive procedure for allocating patients to arms in a finite sample experiment with no early stopping. We evaluate and compare the performance of these procedures, including the traditional and still dominant clinical trial design choice: equal fixed randomization. Our results illustrate how bandit approaches could offer significant advantages, mainly in terms of allocating more patients to better interventions, but still pose important inferential challenges, particularly in terms of their resulting lower statistical power, potential for bias in estimation and existence of closed-form test distributions or asymptotic theory. We illustrate some promising modifications to bandit procedures to address power and bias issues, and we reflect upon the open challenges that remain for an increased uptake of bandit models in clinical trials.

AB - Multi-armed bandit problems (MABPs) are a special type of optimal control problem that has been studied in the fields of operations research, statistics, machine learning, economics, and others. It is a framework well suited to model resource allocation under uncertainty in a wide variety of contexts. Across the existing theoretical literature, the use of bandit models to optimally design clinical trials is one of the most typical motivating application, where the word “optimally” refers to designing the so-called patient-centric trials, which would take into account the benefit of the in-trial patients and thus are by some researchers considered more ethical. Nevertheless, the resulting theory has had little influence on the actual design of clinical trials. Contrary to similar learning problems arising for instance in digital marketing where interventions can be tested on millions of users at negligible cost, clinical trials are about “small data”, as recruiting patients is remarkably expensive and (in many cases) ethically challenging. In this book chapter, we review a variety of operations research and machine learning approaches that lead to algorithms to “solve” the finite-horizon MABP and then interpret them in the context of designing clinical trials. Due to the focus on small sizes, we do not resort to the use of the normal distribution to approximate a binomial distribution which is a common practice for large samples either “for simplicity” or “for ease of computation”. Solving a MABP essentially means to derive a response-adaptive procedure for allocating patients to arms in a finite sample experiment with no early stopping. We evaluate and compare the performance of these procedures, including the traditional and still dominant clinical trial design choice: equal fixed randomization. Our results illustrate how bandit approaches could offer significant advantages, mainly in terms of allocating more patients to better interventions, but still pose important inferential challenges, particularly in terms of their resulting lower statistical power, potential for bias in estimation and existence of closed-form test distributions or asymptotic theory. We illustrate some promising modifications to bandit procedures to address power and bias issues, and we reflect upon the open challenges that remain for an increased uptake of bandit models in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85139013293&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-01926-5_14

DO - 10.1007/978-3-031-01926-5_14

M3 - Chapter

AN - SCOPUS:85139013293

SN - 9783031019258

T3 - Springer Series in Supply Chain Management

SP - 365

EP - 389

BT - Springer Series in Supply Chain Management

A2 - Chen, Xi

A2 - Jasin, Stefanus

A2 - Shi, Cong

PB - Springer Nature

CY - London

ER -